Skip to content

PATRIUS GROUP

Active Public limited companyfounded 2006active for 20 yearsKunstlaan 56, 1000 BrusselsKBO/BCE: BE 0882.014.763

Timeline

41 events since 2006

The 2026 accounts are due by 31-07-2027.

2026
Annual accounts 2025 filed NBBmicro format · on the deadline day
Registered in the Peppol Directory Reachable for e-invoices through 0208:0882014763
Registered office moved from Uccle to BrusselsThe registered office moved from Alsembergsesteenweg 842, 1180 Ukkel to Kunstlaan 56, 1000 Brussel · Permanent representative: · General meeting of 06-01-20263 points ▸
  • General meeting, 06-01-2026
  • Registered-office move, Kunstlaan 56, 1000 Brussel
  • Permanent representative,
  • The deed holds 1 more point.

Open the deed in the Belgian Official Gazette

2025
Annual accounts 2024 filed PDFmicro format · 20 days late
2024
Annual accounts 2023 filed PDFmicro format · 31 days late
1 director appointed, 1 resignationAppointment: · Permanent representatives: and · Resignation: · General meeting of 24-04-20246 points ▸
  • General meeting, 24-04-2024
  • Director appointment,
  • Permanent representative,
  • Director resignation,
  • Director discharge,
  • Permanent representative,

Open the deed in the Belgian Official Gazette

2023
Back to profit net €14,979 The net result is €14,979, after 2 loss-making years.
Annual accounts 2022 filed PDFmicro format · 32 days late
2022
Resignation: (director)Permanent representative: · Director discharge: · General meeting of 10-08-20224 points ▸
  • General meeting, 10-08-2022
  • Director resignation,
  • Director discharge,
  • Permanent representative,

Open the deed in the Belgian Official Gazette

Annual accounts 2021 filed PDFmicro format · 22 days late
Merger: PATRIUS GROUP takes over D-Line Pharma BelgiumCapital of €64,000, 64 shares · General meeting of 03-01-20223 points ▸
  • Merger, 03-01-2022
  • General meeting, 03-01-2022
  • Capital, €64,000, 64 shares
  • The deed holds 2 more points.

Open the deed in the Belgian Official Gazette

2021
Annual accounts 2020 filed PDFabbreviated format · 2 days before the deadline
Merger proposal: Patrius Group takes over D-Line Pharma Belgium BVGeneral meeting of 25-02-20212 points ▸
  • General meeting, 25-02-2021
  • Accounting effect, 01-01-2021
  • The deed holds 3 more points.

Open the deed in the Belgian Official Gazette

Registered office moved from Lier to BrusselsThe registered office moved from Duwijckstraat 17, 2500 Lier to Alsembergsesteenweg 842 te 1180 Brussel · General meeting of 15-12-20202 points ▸
  • General meeting, 15-12-2020
  • Registered-office move, Alsembergsesteenweg 842 te 1180 Brussel

Open the deed in the Belgian Official Gazette

2020
Liquidity more than doubled current ratio 3.99 The current ratio rises from 1.75 to 3.99. Short-term debt falls from €704,041 to €125,211.
Annual accounts 2019 filed PDFabbreviated format · 117 days late
Annual accounts 2018 filed PDFabbreviated format · 168 days late
2019
2 directors reappointed and · Permanent representative: · General meeting of 05-06-20194 points ▸
  • General meeting, 05-06-2019
  • Director reappointment,
  • Director reappointment,
  • Permanent representative,

Open the deed in the Belgian Official Gazette

2018
Equity above €500,000 equity €660,760 ▲35.8% After 6 profitable years in a row, equity reaches €660,760.
Annual accounts 2017 filed PDFabbreviated format · 118 days late
2017
Annual accounts 2016 filed PDFabbreviated format · 29 days late
2016
Annual accounts 2015 filed PDFabbreviated format · 116 days late
Permanent representative: General meeting of 03-03-20162 points ▸
  • General meeting, 03-03-2016
  • Permanent representative,

Open the deed in the Belgian Official Gazette

2015
Equity above €200,000 equity €227,672 ▲40.9% After 3 profitable years in a row, equity reaches €227,672.
Appointment: (director)Resignation: (director) · General meeting of 12-11-20153 points ▸
  • General meeting, 12-11-2015
  • Director appointment,
  • Director resignation,

Open the deed in the Belgian Official Gazette

Annual accounts 2014 filed PDFabbreviated format · 122 days late
2014
Equity above €150,000 equity €161,542 ▲32.7% After 2 profitable years in a row, equity reaches €161,542.
Annual accounts 2013 filed PDFabbreviated format · 61 days late
Registered office moved from Kessel to LierThe registered office moved from Veldstraat 94, 2560 Kessel to Duwijckstraat 17, 2500 Lier · General meeting of 28-02-20142 points ▸
  • General meeting, 28-02-2014
  • Registered-office move, Duwijckstraat 17, 2500 Lier

Open the deed in the Belgian Official Gazette

2013
Back to profit net €209,088 The net result is €209,088, after 2 loss-making years.
Equity above €100,000 equity €121,698 Equity rises from -€87,390 to €121,698.
Annual accounts 2012 filed PDFabbreviated format · 98 days late
2012
Annual accounts 2011 filed PDFabbreviated format · 30 days late
2011
Annual accounts 2010 filed PDFabbreviated format · 27 days before the deadline
2010
Back to profit net €51,297 The net result is €51,297, after 3 loss-making years.
Annual accounts 2009 filed PDFabbreviated format · 31 days late
2009
Liquidity more than 9 times current ratio 3.91 The current ratio rises from 0.39 to 3.91.
Annual accounts 2008 filed PDFabbreviated format · 28 days late
Annual accounts 2007 filed PDFabbreviated format · 195 days late
2006
Incorporation PDFpublished on 03-07-2006
First establishment At the time the registered office was still in Kessel, Veldstraat 94.

Financial milestones sit on the financial year-end date, not the filing date.

Sources: Publications in the Belgian Official GazetteFilings with the National Bank

History

PATRIUS GROUP was incorporated on 22 June 2006.1 The registered office moved to Lier in 2014 and to Brussels in 2021.23 In 2022 the company absorbed D-Line Pharma Belgium by merger.4 Total assets rose from €83,155 in 2022 to €103,902 in 2025.5

  1. 1KBO register
  2. 2Belgian Official Gazette, 22-04-2014
  3. 3Belgian Official Gazette, 12-01-2021
  4. 4Belgian Official Gazette, 19-01-2022
  5. 5National Bank, annual accounts 2022 and 2025

Next steps